Reference 14 - Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage
FDA-2026-P-6541-0016Supporting & Related Material
Document
Details
The document's own metadata, straight from the source system.
- Title
- Reference 14 - Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage
- Posted
- Jun 9, 2026
- Topics